Novo-Nordisk A/S (NVO) Earnings Date & Reports

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

NVO is expected to report earnings to fall 86.00% to 91 cents per share on August 06

Novo-Nordisk A/S NVO Stock Earnings Reports

Q2'25

Est.

$0.91

Q1'25

Beat

by $5.64

Q4'24

Beat

by $5.46

Q3'24

Beat

by $5.24

Q2'24

Beat

by $9.46

The last earnings report on May 07 showed earnings per share of $6.53, beating the estimate of 89 cents. With 4.21M shares outstanding, the current market capitalization sits at 301.75B.

View a ticker or compare two or three

Compare

NVO